Abpro Holdings Inc Sustainability Reports
Abpro Holdings, Inc. is a biotechnology company that focuses on the development of next-generation antibody therapies. The company utilizes its proprietary DiversImmune and MultiMab platforms to engineer novel constructs for immuno-oncology and ophthalmology.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2024 to 2024
Company Profile
Abpro Holdings, Inc. is a biotechnology company that focuses on the development of next-generation antibody therapies. The company utilizes its proprietary DiversImmune and MultiMab platforms to engineer novel constructs for immuno-oncology and ophthalmology.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
